Truist Lifts UnitedHealth (UNH) Price Target on Strong Star Ratings Outlook

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the hot stocks to invest in right now. Truist Securities reaffirmed its Buy rating on UnitedHealth Group Incorporated (NYSE:UNH) and boosted its price target from $310 to $365 on September 9. The hike follows UnitedHealth’s release of an 8-K filing with preliminary 2026 Star ratings data.

Ken Wolter/Shutterstock.com

According to the filing, the company expects around 78% of its membership to be in 4+ Star plans for Payment Year 2027, which aligns with management’s projections and past patterns.

Additionally, UnitedHealth Group Incorporated (NYSE:UNH) reiterated its goal of at least $16 in adjusted earnings per share for the fiscal year 2025, which includes the recently concluded acquisition of Amedisys. The company stated that the acquisition is likely to dilute adjusted EPS slightly due to finance expenses and integration-related investments.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Disclosure: None. This article is originally published at Insider Monkey.